Variant Bio is partnering with Novo Nordisk to study metabolic diseases including obesity, using Variant's genomic data from ...
The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback